0 Members and 1 Guest are viewing this topic.
Nasal spray is by far a better solution, for SARS cov2
Quote from: Jolly2 on 31/01/2021 14:15:00Nasal spray is by far a better solution, for SARS cov2Please provide a reference to your clinical trial.
Yes there are recognised advantages to using a nasal spray for vacination against respiratory diseases. But I imagine not for all types of vaccine. If you want to hear a very brief reference to this I can give you two youtube links - I'm not sure which of the two it's in - 90 minutes each and maybe 30 seconds of relevance to your question. I believe they are developping one in India and Lancaster U has done a trial.
24 million people outside China have taken their inactivated virus vaccine and appear to show less side effects compared to ALL the other vaccine types, and not just for covid
Lancaster U
appear to show less side effects compared to ALL the other vaccine types, and not just for covid
Quote from: Jolly2 on 31/01/2021 15:55:18Lancaster UDo let us know the outcome. And don't forget to tell Lancaster U how long their trial must continue in order tobe valid. You can't trust scientists, statisticians and ethics committees these days - they are all part of a global conspiracy to which you hold the key.
Quote appear to show less side effects compared to ALL the other vaccine types, and not just for covid In other words, it probably doesn't trigger the immune system at all. How very honest of them to admit it.
70% effective with first shoot, 90% with second.
We discussed inhaled vaccines in another thread somewhere. In principle they are of course ideal - self-administered and following the normal entry route of infection. In practice they are less than ideal. The received dose depends on correct procedure and the condition of the nasal passages on induction. Since the nasal system has evolved to trap anything that isn't air, and can envelop particulates in snot that gets blown or spat out or swallowed, the pharmacokinetics of nasal administration is very variable. You need to get the virus or substitute into the lungs and this is usually more effective with oral inhalation which involves less filtration. From there on, the immune system response depends on the active ingredient reaching the bloodstream, so it depends on the condition of the alveolar mucosa and the patient's breathing regimen.
Quote from: Jolly2 on 31/01/2021 20:59:1170% effective with first shoot, 90% with second.Are we talking about the Sinovac vaccine where the actual trial (in Brazil) gave a effectiveness of 50.4%?If not then you need to tell us what you are on about.If it is that vaccine then clearly it hasn't been subject to reliable testing.Why are you advocating it?
If it is that vaccine then clearly it hasn't been subject to reliable testing.Why are you advocating it?
Which is just a question about administration of the vaccine. A nasal spray can be administered more then once also.
Quote from: Jolly2 on 01/02/2021 14:04:46Which is just a question about administration of the vaccine. A nasal spray can be administered more then once also.OK, how many doses are required for effectiveness in all cases? What is the maximum safe dose in all cases? How do you know when you have received the right amount in the right place? Of course it's about administration. Most vaccines are administered by injection or orally, and you are advocating nasal administration. I've pointed out why other routes are generally more reliable and controllable.
They are all questions for the trails.
How long should a Vaccine Trial take?
Quote from: Jolly2How long should a Vaccine Trial take?From what I have heard, it takes somewhere around 196 infections to complete the efficacy trial of a vaccine.- If there are practically no cases of the disease in the population, the trial can take forever- If the disease is running riot (as in Brazil), the trial doesn't need to take nearly as long.
If you have a blinded, randomized, placebo-controlled trial (the gold standard), half of the participants will be randomly selected to get the vaccine, and the other half will only think they got the vaccine.- By the time 196 people catch the disease, you can compare how many of these had received the vaccine, and how many received the placebo.- If 90% of the infections are in the placebo arm, then you can say the vaccine has very high efficacy. Now, I am sure there is some reason why they picked a number like 196 infections.- Probably to do with the minimum number of infections to provide a 95% confidence in the efficacy resultsHow long the trials should last for safety is determined by entirely different measures - you are looking for rare side-effects, and this typically means enrolling around 30,000 people in the trial, half of whom will receive the vaccine.- You compare the extent of side-effects in the people vaccinated vs non-vaccinated- Salt water does not make a good placebo, as it has almost no side-effects (apart from a sore arm)- One of the vaccine trials gave the placebo subjects a vaccine for a different virus, which better simulates the side-effects of activating your immune system, and possible allergic reactions.
Let's just wait and see what happens to the people who've been injected with the "vaccine"Perhaps they'll be OK. I hope so.But I'd rather be cautious.
The inactivated virus vaccines have far more historic data related to them. The chiense inactivated virus vaccine and appear to show less side effects compared to ALL the other vaccine types
I believe there should also be a concern with antibodies dependent enhancement. ADE.
While the process isn't totally clear and needs research,